Shopping Cart
- Remove All
- Your shopping cart is currently empty
Amlitelimab (KY1005) is a monoclonal antibody targeting OX40 ligand (OX40L), inhibiting KLH-driven immune responses, used in the study of atopic dermatitis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $197 | In Stock | |
5 mg | $516 | In Stock | |
10 mg | $828 | In Stock | |
25 mg | $1,230 | In Stock | |
50 mg | $1,650 | In Stock |
Description | Amlitelimab (KY1005) is a monoclonal antibody targeting OX40 ligand (OX40L), inhibiting KLH-driven immune responses, used in the study of atopic dermatitis. |
In vitro | Amlitelimab (150 μg/mL) effectively inhibits the proliferation of human CD3 T cells [3]. |
In vivo | In non-human primate graft-versus-host disease (GVHD) models, treatment with Amlitelimab (10mg/kg) showed significant biological activity (extending median GVHD free survival from 8 days to 19.5 days). [1] |
Alias | SAR445229, SAR 445229, KY1005, KY 1005 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.